Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,073
Total Claims
$999K
Drug Cost
466
Beneficiaries
$2,145
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
-95%
Opioid rate vs peers
0.1% vs 2.5% avg
+90%
Cost per patient vs peers
$2,145 vs $1,128 avg
+147%
Brand preference vs peers
20.7% vs 8.4% avg
Opioid Prescribing
0.1%
Opioid Rate
13
Opioid Claims
$77
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,059 claims · $870K
Generic: 7,870 claims · $127K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phos/Metformin Hcl | 88 | $118K |
| Dapagliflozin Propanediol | 81 | $101K |
| Empaglifloz/Linaglip/Metformin | 45 | $49K |
| Sitagliptin Phosphate | 29 | $44K |
| Insulin Glargine,hum.Rec.Anlog | 76 | $40K |
| Empagliflozin | 39 | $38K |
| Rivaroxaban | 36 | $34K |
| Sitagliptin Phos/Metformin Hcl | 25 | $29K |
| Apixaban | 43 | $29K |
| Levothyroxine Sodium | 423 | $28K |
| Fluticasone Propionate | 75 | $24K |
| Varicella-Zoster Ge/As01b/Pf | 113 | $22K |
| Oxcarbazepine | 19 | $21K |
| Cyclosporine | 36 | $19K |
| Tiotropium Bromide | 34 | $18K |
Prescribing Profile
Patient Profile
71
Avg Age
56%
Female
1.56
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data